Sale!

SMC1A Gene Cornelia de Lange Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “SMC1A Gene Cornelia de Lange Syndrome Type 2 Genetic Test” is a specialized diagnostic tool available at DNA Labs UAE, aimed at detecting mutations in the SMC1A gene, which are associated with Cornelia de Lange Syndrome (CdLS) Type 2. Cornelia de Lange Syndrome is a rare genetic disorder that can affect multiple parts of the body and is characterized by distinctive facial features, growth delays, intellectual disability, and limb defects. The test is crucial for early diagnosis and management of the syndrome, allowing for tailored care and interventions to improve the quality of life for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations linked to this condition. By offering this test, DNA Labs UAE provides essential support to families seeking answers about this complex syndrome, facilitating access to genetic counseling and appropriate medical care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SMC1A Gene Cornelia de Lange syndrome type 2 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for SMC1A Gene Cornelia de Lange syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMC1A Gene Cornelia de Lange syndrome type 2 NGS Genetic DNA Test gene SMC1A.

Test Details

The SMC1A gene is associated with Cornelia de Lange syndrome type 2 (CdLS2). CdLS is a genetic disorder that affects multiple organ systems and is characterized by intellectual disability, distinctive facial features, growth retardation, and limb abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a method used to sequence and analyze multiple genes simultaneously. It allows for the identification of genetic variants or mutations that may be associated with specific disorders or conditions. In the context of CdLS2, an NGS genetic test targeting the SMC1A gene would involve sequencing the entire coding region of the gene to identify any potential disease-causing mutations or variants.

This type of test can help confirm a diagnosis of CdLS2 in individuals suspected of having the condition. It is important to note that genetic testing for CdLS and other genetic disorders should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate genetic counseling.

Test Name SMC1A Gene Cornelia de Lange syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SMC1A Gene Cornelia de Lange syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMC1A Gene Cornelia de Lange syndrome type 2 NGS Genetic DNA Test gene SMC1A
Test Details

The SMC1A gene is associated with Cornelia de Lange syndrome type 2 (CdLS2). CdLS is a genetic disorder that affects multiple organ systems and is characterized by intellectual disability, distinctive facial features, growth retardation, and limb abnormalities.

NGS (Next-Generation Sequencing) genetic testing is a method used to sequence and analyze multiple genes simultaneously. It allows for the identification of genetic variants or mutations that may be associated with specific disorders or conditions.

In the context of CdLS2, an NGS genetic test targeting the SMC1A gene would involve sequencing the entire coding region of the gene to identify any potential disease-causing mutations or variants. This type of test can help confirm a diagnosis of CdLS2 in individuals suspected of having the condition.

It is important to note that genetic testing for CdLS and other genetic disorders should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate genetic counseling.